An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody is a research paper published in mBio (2023). On theSindex it has a DataRank of 0.444. It has been cited 8 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.114
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
Mount Sinai Innovation Partners
Grant: iP3
HHS | National Institutes of Health
Grant: T32-AI007647
HHS | National Institutes of Health
Grant: R01AI139258, R21AI147632
HHS | National Institutes of Health
Grant: RF1AG059319
HHS | National Institutes of Health
Grant: R01AI168178
National Institutes of Health
Grant: 5R21AI147632-02
Delineating the mechanism and inhibitory capacity of CMV neutralizing antibodies
National Institutes of Health
Grant: 5U24GM129539-04
NCCAT: National Center for CryoEM Access and Training
National Institutes of Health
Grant: 1R01AI168178-01
Structural interrogation of vaccine- and infection-induced B cell responses
National Institutes of Health
Grant: 1RF1AG059319-01
SYSTEMATIC DRUG REPURPOSING TARGETING IMMUNE ACTIVATION NETWORKS IN ALZHEIMER'S DISEASE (AD)
National Institutes of Health
Grant: 5T32AI007647-15
TRAINING PROGRAM IN MECHANISMS OF VIRUS-HOST INTERACTIONS
National Institutes of Health
Grant: 1R01AI139258-01A1
Identification of human cytomegalovirus life cycle stage-specific therapeutics
Fields of Study
Keywords
Sustainable Development Goals